title: CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.
abstract: In light of the adverse side-effects of opioids, cannabinoid receptor agonists may provide an effective alternative for the treatment of cancer pain. This study examined the potency and efficacy of synthetic CB1 and CB2 receptor agonists in a murine model of tumor pain. Intraplantar injection of the CB1 receptor agonist arachidonylcyclopropylamide (ED(50) of 18.4 μg) reduced tumor-related mechanical hyperalgesia by activation of peripheral CB1 but not CB2 receptors. Similar injection of the CB2 receptor agonist AM1241 (ED50 of 19.5 μg) reduced mechanical hyperalgesia by activation of peripheral CB2 but not CB1 receptors. Both agonists had an efficacy comparable with that of morphine (intraplantar), but their analgesic effects were independent of opioid receptors. Isobolographic analysis of the coinjection of arachidonylcyclopropylamide and AM1241 determined that the CB1 and CB2 receptor agonists interacted synergistically to reduce mechanical hyperalgesia in the tumor-bearing paw. These data extend our previous findings that the peripheral cannabinoid receptors are a promising target for the management of cancer pain and mixed cannabinoid receptor agonists may have a therapeutic advantage over selective agonists.
authors: Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA.
authors: Iryna A
authors: IA
authors: Khasabova
authors: James
authors: J
authors: Gielissen
authors: Anisha
authors: A
authors: Chandiramani
authors: Catherine
authors: C
authors: Harding-Rose
authors: Desiree Abu
authors: DA
authors: Odeh
authors: Donald A
authors: DA
authors: Simone
authors: Virginia S
authors: VS
authors: Seybold
references: Br J Pharmacol. 2008 Nov;155(6):913-24
references: 18695638
references: J Neurosci. 2008 Oct 29;28(44):11141-52
references: 18971457
references: Br J Pharmacol. 2009 Feb;156(3):397-411
references: 19226257
references: Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72
references: 16316650
references: Oncology (Williston Park). 1999 May;13(5 Suppl 2):25-9
references: 10356695
references: Br J Pharmacol. 2008 Jan;153(2):319-34
references: 17994113
references: Pharmacol Biochem Behav. 2008 Nov;91(1):38-46
references: 18611408
references: Chem Biol. 2007 Dec;14(12):1357-65
references: 18096504
references: Br J Pharmacol. 1999 Feb;126(3):665-72
references: 10188977
references: Eur J Pharmacol. 2008 Mar 31;583(1):56-61
references: 18279850
references: J Pharmacol Exp Ther. 1999 Jun;289(3):1427-33
references: 10336536
references: J Neurosci. 2001 Dec 1;21(23):9367-76
references: 11717370
references: Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):627-36
references: 19152053
references: Life Sci. 2010 Apr 24;86(17-18):646-53
references: 20176037
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3093-8
references: 15705714
references: Brain Res. 2008 Jun 18;1215:69-75
references: 18486111
references: Nature. 2005 Jun 23;435(7045):1108-12
references: 15973410
references: Anesthesiology. 2000 Sep;93(3):765-73
references: 10969310
references: J Neurosci. 2007 Sep 19;27(38):10289-98
references: 17881535
references: Br J Pharmacol. 2008 Jan;153(2):390-401
references: 17994110
references: AAPS PharmSci. 1999;1(2):E4
references: 11741201
references: Br J Pharmacol. 2011 Jan;162(2):428-40
references: 20880025
references: Curr Top Med Chem. 2008;8(3):187-204
references: 18289088
references: Brain Res Rev. 2009 Apr;60(1):255-66
references: 19150370
references: Nat Med. 2009 Jul;15(7):802-7
references: 19525966
references: Neurosci Lett. 2008 Mar 12;433(2):77-81
references: 18242856
references: Pain. 2007 Dec 5;132(3):312-320
references: 17916403
references: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14228-33
references: 10588688
references: Nature. 1993 Sep 2;365(6441):61-5
references: 7689702
references: J Neurosci. 2001 Dec 1;21(23):9355-66
references: 11717369
references: Nat Neurosci. 2007 Jul;10(7):870-9
references: 17558404
references: Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31
references: 19285265
references: Clin J Pain. 2011 Jan;27(1):9-18
references: 20842024
references: J Immunol. 2006 Dec 15;177(12):8796-805
references: 17142782
references: Br J Pharmacol. 2010 Jun;160(3):561-73
references: 20233215
references: Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
references: 17062708
references: J Pain. 2004 Nov;5(9):491-7
references: 15556827
references: Cancer. 1989 Jun 1;63(11 Suppl):2298-307
references: 2655867
references: Anesthesiology. 2003 Oct;99(4):955-60
references: 14508331
references: J Pharmacol Exp Ther. 2009 Jan;328(1):141-51
references: 18931146
references: J Clin Oncol. 2004 Sep 1;22(17):3587-92
references: 15337809
references: Neuroscience. 2008 Feb 6;151(3):843-53
references: 18178319
references: Biochem J. 2004 Jun 1;380(Pt 2):329-38
references: 14967069
references: Eur J Pharmacol. 2007 Mar 8;558(1-3):73-87
references: 17250825
references: Expert Opin Investig Drugs. 2005 Jun;14(6):695-703
references: 16004597
references: Neuroscience. 2000;98(3):585-98
references: 10869852
references: Pain. 1992 Apr;49(1):93-97
references: 1594286
references: Pain. 2006 May;122(1-2):36-42
references: 16563625
references: J Clin Invest. 2003 Jan;111(1):43-50
references: 12511587
references: Nature. 1990 Aug 9;346(6284):561-4
references: 2165569
references: Pain. 2001 Sep;93(3):239-245
references: 11514083